Use the Back button in your browser to see the other results of your search or to select another record.
The effects of a pedometer-based behavioral modification program with telephone support on physical activity and sedentary behavior in type 2 diabetes patients [with consumer summary] |
de Greef KP, Deforche BI, Ruige JB, Bouckaert JJ, Tudor-Locke CE, Kaufman J-M, de Bourdeaudhuij IM |
Patient Education and Counseling 2011 Aug;84(2):275-279 |
clinical trial |
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
OBJECTIVE: Effectiveness of a behavioral modification program on physical activity (PA) and sedentary behavior in diabetes patients. METHODS: Ninety-two patients were randomly assigned to an intervention or control group. The 24-weeks intervention consisted of a face-to-face session, pedometer and seven telephone follow-ups. Mean selection criteria were 35 to 75 years; 25 to 35 kg/m2; <= 12% HbA1c, treated for type 2 diabetes; no PA limitations. PA and sedentary behavior were measured by pedometer, accelerometer and questionnaire over the short- (24 weeks) and intermediate- (1 year) term. RESULTS: The intervention group increased their steps/day by 2,744, their total PA by 23 min/day (p < 0.001) and decreased their sedentary behavior by 23 min/day (p < 0.05) post-intervention. After 1 year the intervention group still had an increase of 1,872 steps/day, 11 min/day total PA and a decrease of 12 min/day in sedentary behavior (p < 0.001). CONCLUSION: This pedometer-based behavioral modification program with telephone support showed lasting positive effects on steps/day, PA and sedentary behavior. PRACTICE IMPLICATIONS: This study tested a convenient way to increase PA among type 2 diabetes patients.
|